Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +1.53% | -7.64% | +95.59% |
Apr. 18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
Apr. 18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
Business Summary
Number of employees: 33
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 10-07-05 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | Dec. 10 |
Khursheed Anwer
CTO | Chief Tech/Sci/R&D Officer | 64 | 14-06-19 |
Kimberly Bragg
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-07 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 11-07-07 |
James Dentzer
BRD | Director/Board Member | 57 | 22-10-02 |
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Donald Braun
BRD | Director/Board Member | 74 | 15-12-14 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 21-06-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,399,811 | 9,291,441 ( 98.85 %) | 22 ( 0.000234 %) | 98.85 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+95.59% | 12.5M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- IMNN Stock
- Company Imunon, Inc.